Category: Hot Opportunities

LBPS Stock
Hot Opportunities

NanoViricides Inc. (NNVC) Stock Surges Following the Completion of Licensing for Coronavirus Field

NanoViricides Inc. (NNVC) stock prices surged by 14.50% around the time market trading commenced on September 14th, 2021. This brought the price per share up to USD$4.66 early on in the trading day. NNVC Stock’s Licensing Completion September 14th, 2021 saw NNVC stock announce the completion of the process of licensing the human Coronavirus field for drug development and commercialization from TheraCout Pharma Inc. The global leader in nanomedicines against viruses executed a license agreement on September 8th, 2021. This agreement was for the field, consisting of anti-viral treatments for the global coronavirus pandemic. These treatments were derived from human

Hot Opportunities

Communications Systems Inc. (JCS) Stock Surges Following Announcement of Special Dividend

Communications Systems Inc. (JCS) stock prices were up by 0.59% as of the market closing on September 13th, 2021. This brought the price per share up to USD$6.79 at the end of the trading day. Subsequent premarket fluctuations saw the stock surge by 30.49%, bringing it up to USD$8.86. JCS Stock Announces Dividend September 13th 2021 saw the company’s board of directors declare a special dividend of USD$3.50 per share. The dividend will be payable on October 15th 2021 to shareholders of record of JCS stock at the close of the business on September 30th 2021. The aggregate amount of

Hot Opportunities

Leap Therapeutics Inc. (LPTX) Stock Surges Following Successful Initial Data from DisTinGuish Clinical Trial

Leap Therapeutics Inc. (LPTX) stock prices were down by 2.67% as of the market closing on September 10th, 2021. This brought the price per share down to USD$1.46 at the end of the trading day. Subsequent premarket fluctuations have seen the stock surge by 28.08%, bringing it up to USD$1.87. Success of Initial Data September 13th, 2021 saw LPTX stock announce its plan to present initial data from its first-line cohort of the DisTinGuish study. The study is a Phase 2a clinical trial that is designed to evaluate the company’s anti-Dickkopf-1 (DKK1) antibody, DKN-01. The treatment will be administered in

META Stock
Hot Opportunities

Cyren Ltd. (CYRN) stock rising in the Pre-Market today: Let’s find out why

Shares of the Cyren Ltd. (CYRN) stock were rising in the pre-market trading session today without any obvious reason. CYRN stock price saw a push of 21.83% to reach $0.73 a share at the time of this writing. The trading volume as of now was 7,729,004. The stock was also green in the previous trading and went up by 15.79% at closing. Cyren Ltd is the security solution provider is an Israeli-based company that provides information security solutions to businesses across the globe. Let’s dig in to explore more about this stock. CYRN stock Partners with Improving: CYRN stock on

Hot Opportunities

North Dynasty Mining (NAK) stock surged 7.87% today, here’s why

Northern Dynasty Minerals Ltd. (NAK) explores minerals in the United States. Its main mineral asset is the Pebble copper-gold-molybdenum project, with 2,402 mineral claims, covering an area of ​​approximately 417 square miles, located in southwest Alaska. The company’s predecessor was Northern Dynasty Exploration Ltd. changed its name to Northern Dynasty Mining Ltd. in October 1997. Northern Dynasty Mining Ltd. was established in 1983 and is now headquartered in Vancouver, Canada.  Overview Pebble Project When it comes to the features of Project Pebble, there are a lot of big data to ask. For example, this resource is equivalent to 1.9% of

JNJ Stock
Hot Opportunities

Biotech Stocks to Buy to Start the Week

Biotechnology (biotech) refers to the use of microbes and cellular biology in health-related research and development. It is not just therapies that biotechnology companies develop. Many fields are embracing biotech, including healthcare, medicine, and related processes. Investing in biotechnology stocks involves a risk because companies spend a lot of time and resources developing drugs that might never reach the shelves. A biotech product must usually undergo research and fundraising before the FDA (Food and Drug Administration) approves it. A drug can take years to become profitable after they have been developed. Analysts, however, believe biotechnology has reached its peak. Today,

Hot Opportunities

There Is Clear Momentum For Trimble Inc. (TRMB) Stock

Trimble Inc. (NASDAQ: TRMB) manufactures automation tools for industrial and agricultural equipment. The company recently released a strong report for the second quarter of 2021. TRMB exceeded expectations and also launched its own venture capital fund for innovation. Trimble Inc. (TRMB) had record revenues of $945 million (+ 29% year-over-year) in the past quarter. Recurring revenues increased by 11% while operating cash flow increased by 42% to $797.6 million. The company earned $0.55 per diluted share. Growth in key segments helped the company to achieve its best performance in history. Firstly, these are construction, agricultural, cartography, and infrastructure management equipment

META Stock
Hot Opportunities

Prospects Appear Solid: Chewy Inc. (CHWY) Stock

Online pet retailer Chewy Inc. (NYSE: CHWY) has seen its promotions gain more than 50% in the past year. The company increased its number of customers and their spending on platforms during the COVID-19 pandemic. It seems like Chewy Inc. (CHWY) has no plans to slow its growth rate despite the changing situation. It is becoming increasingly popular to supply pet supplies, and the ongoing COVID-19 outbreak has only accelerated this trend. In particular, many people adopted pets during forced self-isolation. The new owners soon became Chewy online store customers. Today, there are three main product categories on the Chewy

Hot Opportunities

Why Code Chain New Continent Limited (CCNC) Is A Good Stock To Buy In Long Run

Code Chain New Continent Limited (CCNC), a leading eco-tech company operating through its subsidiaries, saw a plunge in its share price on Tuesday, as its share price fell to $1.73, a decrease of about $0.42. Currently, in the premarket, the company is gaining back some of its lost momentum, with the share price increasing to about 5.78%, and hence, is being traded at $1.83. CCNC during last 12 months Last 12 months have seen the fluctuation within CCNC stock. From July 2020 till February 2021, the average share price of its stock was about $1.5. In early February, the company

Hot Opportunities

Acasti Pharma Inc. (ACST) stock keeps trending higher, Here’s what you should know

Acasti Pharma Inc. (NASDAQ: ACST) is a Canadian company operating in the biotechnology industry. It is one of the top 10 biopharmaceutical stocks showing strong bullish trends in NASDAQ, at the current market price of $0.60, with a market cap of $119.35M. On June 22nd, 2021 the company published its Fiscal 2021 year-end business update that soared the stock price up by +10.444%. In the FY21 business update, the company reported the cash and cash equivalent totaled 50.9 million as compared to ‎$‎14.2 million as of March 31st, 2020. The company also shared a net loss of ‎$‎19.7 million or